COMMUNIQUÉS West-GlobeNewswire

Auris Medical Announces Extraordinary General Meeting of Shareholders

09/02/2018 - 14:00

Proposed capital restructuring to ensure compliance with Nasdaq minimum bid price rule contingent on Company's share price development Alain Munoz proposed as new member of the Board of the Directors Zug, Switzerland, [...]

iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference

09/02/2018 - 14:00

iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]

Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference

09/02/2018 - 14:00

YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]

Ogilvy CommonHealth Worldwide’s Reilly and Logan Inducted Into the Medical Advertising Hall of Fame's Future Famers Program

09/02/2018 - 14:00

PARSIPPANY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Lindsey Reilly, senior [...]

LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018

09/02/2018 - 14:00

BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the [...]

Immune Design to Present at Upcoming Investor Conferences

09/02/2018 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy company focused on next-generation therapies in oncology, today announced that senior management [...]

The American Health Council Appoints Michael Mahla, MD to Physician Board

09/02/2018 - 14:00

NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Michael Mahla, MD is selected to the American Health Council’s Board of Physicians for his outstanding contributions to the medical field. As a professor and executive vice [...]

Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics

09/02/2018 - 14:00

SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB 2679d/ISU304 in Individuals with Hemophilia B

09/02/2018 - 13:30

All individuals with severe hemophilia improved to mild hemophilia activity levels after only six daily doses with a continuous linear increase in Factor IX clotting activity These results suggest that long-term dosing [...]

Summit Therapeutics to Participate in Upcoming Investor Conferences

09/02/2018 - 13:01

Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES Oxford, UK, 9 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]

Summit Therapeutics to Participate in Upcoming Investor Conferences

09/02/2018 - 13:00

OXFORD, United Kingdom, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]

Bio-Path Holdings Announces 1-for-10 Reverse Stock Split

09/02/2018 - 13:00

HOUSTON, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

09/02/2018 - 13:00

MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing of its previously [...]

Lotus Enters “Active Review” with Health Canada & Closes Cannabis Financing of $1 Million

09/02/2018 - 13:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc (CSE:J) (the " Company ") announced today that [...]

pSivida to Present at the 2018 BIO CEO & Investor Conference

09/02/2018 - 13:00

WATERTOWN, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]

AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017

09/02/2018 - 13:00

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

Novo Nordisk A/S: Ozempic® (semaglutide) approved in the EU for the treatment of type 2 diabetes

09/02/2018 - 12:36

Bagsværd, Denmark, 9 February 2018 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Ozempic ® (semaglutide) for the treatment of adults with type 2 diabetes. [...]

Achillion to Present at the Leerink Partners 7th Annual Global Healthcare Conference

09/02/2018 - 12:05

NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will participate in a [...]

ContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference

09/02/2018 - 12:00

EDISON, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]